Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 23;15(5):1107.
doi: 10.3390/nu15051107.

Polyphenols Mediate Neuroprotection in Cerebral Ischemic Stroke-An Update

Affiliations
Review

Polyphenols Mediate Neuroprotection in Cerebral Ischemic Stroke-An Update

Salaheldin Abdelraouf Abdelsalam et al. Nutrients. .

Abstract

Stroke is one of the main causes of mortality and disability, and it is due to be included in monetary implications on wellbeing frameworks around the world. Ischemic stroke is caused by interference in cerebral blood flow, leading to a deficit in the supply of oxygen to the affected region. It accounts for nearly 80-85% of all cases of stroke. Oxidative stress has a significant impact on the pathophysiologic cascade in brain damage leading to stroke. In the acute phase, oxidative stress mediates severe toxicity, and it initiates and contributes to late-stage apoptosis and inflammation. Oxidative stress conditions occur when the antioxidant defense in the body is unable to counteract the production and aggregation of reactive oxygen species (ROS). The previous literature has shown that phytochemicals and other natural products not only scavenge oxygen free radicals but also improve the expressions of cellular antioxidant enzymes and molecules. Consequently, these products protect against ROS-mediated cellular injury. This review aims to give an overview of the most relevant data reported in the literature on polyphenolic compounds, namely, gallic acid, resveratrol, quercetin, kaempferol, mangiferin, epigallocatechin, and pinocembrin, in terms of their antioxidant effects and potential protective activity against ischemic stroke.

Keywords: epigallocatechin; gallic acid; ischemia stroke; kaempferol; mangiferin; oxidative stress; pinocembrin; quercetin; resveratrol.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Effects of gallic acid on ischemic stroke (image created using biorender.com (accessed on 21 October 2022)).
Figure 2
Figure 2
Effects of resveratrol on ischemic stroke (image created using biorender.com (accessed on 21 October 2022)).
Figure 3
Figure 3
Effects of quercetin on ischemic stroke (image created using biorender.com (accessed on 21 October 2022)).
Figure 4
Figure 4
Effects of kaempferol on ischemic stroke (image created using biorender.com (accessed on 21 October 2022)).
Figure 5
Figure 5
Effects of mangiferin, epigallocatechin, and pinocembrin on stroke.

References

    1. Campbell B.C., De Silva D.A., Macleod M.R., Coutts S.B., Schwamm L.H., Davis S.M., Donnan G.A. Ischaemic stroke. Nat. Rev. Dis. Prim. 2019;5:70. doi: 10.1038/s41572-019-0118-8. - DOI - PubMed
    1. Xian Y., Holloway R.G., Chan P.S., Noyes K., Shah M.N., Ting H.H., Chappel A.R., Peterson E.D., Friedman B. Association between stroke center hospitalization for acute ischemic stroke and mortality. Jama. 2011;305:373–380. doi: 10.1001/jama.2011.22. - DOI - PMC - PubMed
    1. Johnson W., Onuma O., Owolabi M., Sachdev S. Stroke: A global response is needed. Bull. World Health Organ. 2016;94:634. doi: 10.2471/BLT.16.181636. - DOI - PMC - PubMed
    1. Afshari L., Amani R., Soltani F., Haghighizadeh M.H., Afsharmanesh M.R. The relation between serum Vitamin D levels and body antioxidant status in ischemic stroke patients: A case–control study. Adv. Biomed. Res. 2015;4:13. - PMC - PubMed
    1. Rodrigo R., Fernández-Gajardo R., Gutiérrez R., Manuel Matamala J., Carrasco R., Miranda-Merchak A., Feuerhake W. Oxidative stress and pathophysiology of ischemic stroke: Novel therapeutic opportunities. CNS Neurol. Disord.-Drug Targets (Former. Curr. Drug Targets-CNS Neurol. Disord.) 2013;12:698–714. doi: 10.2174/1871527311312050015. - DOI - PubMed